Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Androgen receptor expression in Iraqi women with breast cancer has limited prognostic value.

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.

GnRH treatment can reduce breast cancer cell invasion.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Truncated hHb1 keratin may play a role in breast cancer cell transformation.

A new method accurately measures cell changes in breast cancer.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.